Having observed that Tf-conjugated fluorophores were hardest to trace in smaller tumor lesions (Figs 4 and 6), we set out to test the effects of DFO at an earlier stage of the diffuse Bo1 tumor model, characterized by significantly lower tumor burden. Here, TF is linked to neoplasm.